Pitofsky Jason
SVP Controller
Pitofsky Jason has filed 3 SEC Form 4 filings (15 transaction rows) across 1 company, with disclosures dating back to 2025. 3 of those filings fall inside the rolling window. Most recent filing: Feb 11, 2026.
On the most recent filing, Pitofsky Jason is listed as SVP Controller at REGENERON PHARMACEUTICALS, INC. Inside the rolling window, Pitofsky Jason reported no open-market purchases and 2 open-market sales totaling $1.9M in REGN. The largest disclosed transaction in the window is a sale of 2,036 REGN shares on Feb 9, 2026, worth $1.6M.
Companies traded
Other insiders at REGN
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$1.9M
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Pitofsky Jason made?
Pitofsky Jason has filed 3 SEC Form 4 filings (15 transaction rows) across 1 company since 2025.
Which companies does Pitofsky Jason trade?
Pitofsky Jason has filed SEC Form 4 disclosures for 1 company, including REGN.
When was Pitofsky Jason's most recent SEC Form 4 filing?
Pitofsky Jason's most recent SEC Form 4 filing on Tracefour is dated Feb 11, 2026.
What is Pitofsky Jason's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Pitofsky Jason is listed as SVP Controller.
What is Pitofsky Jason's total buy and sell value in the current window?
Inside the rolling retention window, Pitofsky Jason bought $0 and sold $1.9M based on SEC Form 4 filings.
What was Pitofsky Jason's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 2,036 REGN shares on 2026-02-09, worth $1.6M, per SEC Form 4 filings.